PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to various viruses, as well as various antigens in human serum or plasma.
- (22.Feb.2021) PCL, Corona 19 Antibody and Antigen Rapid Diagnosis Kit, Mutant Viruses Also High in Diagnosis Utility
- (02.Feb.2021) PCL Expects to Bid for the Red Cross Immunity Test System
- (29.Jan.2021) PCL Corona Antigen Test Kit, Licensed for Private Sale in Austria
- (29.Dec.2020) PCL "Achieves 10% Market Share of in Vitro Diagnostic Kits"
- (06.May.2020) QuestCap and MTJR Partnership Signs Sales Agreement for 500,000 Antibody Tests
- (08.Apr.2020) Four Korean Companies Including PCL and SD Biosensors Corona 19 Diagnostic Kit Product FDA Product Registration
- (02.Apr.2020) PCL Prepares to Supply New Coronavirus Molecular Diagnostic Reagent
- (19.Mar.2020) Two Rapid Diagnostic Kits, the First in Korea to Simultaneously Export European CE-VID Certified RT-PCR Reagents to Europe